| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-9236(98)90018-2 |
| P698 | PubMed publication ID | 9695715 |
| P50 | author | Johan Gabrielsson | Q42890327 |
| P2093 | author name string | Steiner E | |
| Koike Y | |||
| von Bahr C | |||
| P2860 | cites work | Influence of route of administration on drug availability | Q34226637 |
| Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. | Q34283194 | ||
| Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension | Q34416708 | ||
| The influence of enzyme induction on polymorphic sparteine oxidation | Q34447764 | ||
| Phenobarbital induction of cytochrome P-450 gene expression | Q35887158 | ||
| Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications | Q36093642 | ||
| Enzyme induction in the cytochrome P-450 system | Q38140216 | ||
| The role of Barbie box sequences as cis-acting elements involved in the barbiturate-mediated induction of cytochromes P450BM-1 and P450BM-3 in Bacillus megaterium | Q38297907 | ||
| Influence of pentobarbital on metoprolol plasma levels | Q41731335 | ||
| Partial metabolic clearances as determinants of the oral bioavailability of propranolol | Q42015699 | ||
| First-pass metabolism of nortriptyline in man | Q42597560 | ||
| Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation | Q43434705 | ||
| Pentobarbital elimination in patients with poor renal function | Q53798758 | ||
| Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects. | Q53909148 | ||
| Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism | Q61794937 | ||
| Effect of pentobarbital on the disposition of alprenolol | Q67653134 | ||
| Gas chromatographic determination of barbiturates by extractive alkylation and support coated open tubular column separation | Q67697171 | ||
| The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine | Q68183654 | ||
| Kinetic models of induction: I. Persistence of the inducing substance | Q69494403 | ||
| Dose-dependent enzyme induction | Q69559046 | ||
| Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations | Q69582092 | ||
| Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects | Q69588593 | ||
| Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities | Q69936283 | ||
| Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man | Q69948291 | ||
| Correlation between nortriptyline and debrisoquine hydroxylation in the human liver | Q70442262 | ||
| E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation | Q70823716 | ||
| Multidose studies in the human metabolism of pentobarbitone | Q71265109 | ||
| Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy | Q71347970 | ||
| Phenobarbital induces the 2-hydroxylation of desipramine | Q71633126 | ||
| Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A induction | Q71895507 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 18-26 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism | |
| P478 | volume | 64 |
| Q46981944 | A mechanism-based integrated pharmacokinetic enzyme model describing the time course and magnitude of phenobarbital-mediated enzyme induction in the rat. |
| Q43685117 | A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide |
| Q36053763 | A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients |
| Q46233590 | A mechanism-based population pharmacokinetic model for characterizing time-dependent pharmacokinetics of midostaurin and its metabolites in human subjects |
| Q37219133 | Accidental Overdose of Oral Cyclosporine in Haematopoietic Stem Cell Transplantation: A Case Report and Literature Review |
| Q32117273 | Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites |
| Q60596730 | Dealing with Time-Dependent Pharmacokinetics during the Early Clinical Development of a New Leukotriene B4 Synthesis Inhibitor |
| Q38372360 | Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinet |
| Q36055447 | Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM. |
| Q52334679 | Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A. |
| Q40306549 | Mechanisms and Consequences of Drug-Drug Interactions |
| Q77831624 | Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs |
| Q28081063 | Pattern Recognition in Pharmacokinetic Data Analysis |
| Q46922851 | Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin |
| Q34597852 | Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptyline |
| Q44872854 | Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. |
| Q36054984 | Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes |
| Q35029490 | Role of variability in explaining ethanol pharmacokinetics: research and forensic applications |
| Q35956204 | The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man. |
Search more.